EUVIMEDEUVIMED entdecken
Validierungsstudie

Validation of Clinical Practice Research Datalink ( CPRD ) Aurum Mother‐Baby Link

Catherine Vasilakis-Scaramozza iD, Rebecca Persson, George Kafatos, David Neasham, Katrina Wilcox Hagberg, Susan Jick iD

Pharmacoepidemiology and Drug Safety · 2025-02 · 34 (2)

DOI: 10.1002/pds.5860 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 17.02.2025. Verfasst von Catherine Vasilakis-Scaramozza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts, USA. Hauptthemen laut MEDLINE: Databases, Factual, Medical Record Linkage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Amgen Inc, Amgen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Assess the validity of the Clinical Practice Research Datalink (CPRD) Aurum Mother‐Baby Link (MBL).

Methods

We assessed the validity of CPRD Aurum MBL pairs using several strategies. Our study population was based on all available MBL pairs in a 100‐practice sample of CPRD Aurum. We sent a questionnaire to the general practitioner of a sample of MBL patients asking if linkage was correct and whether delivery date was correct within 14 days. We also compared MBL delivery date to the matched child's birth date in CPRD Aurum. Finally, in the Hospital Episode Statistics (HES) eligible population, we compared MBL delivery date to birthing parent's HES delivery date.

Results

The study population included 124 962 MBL pairs: 124 962 livebirths, 91 218 birthing parents, and 123 562 deliveries. Based on 361 questionnaire responses standardized to the MBL population, 85% (95% CI 74%–96%) of pairs were confirmed as correctly matched,

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Databases, FactualMedical Record LinkageHumansFemaleSurveys and QuestionnairesPregnancyInfant, NewbornAdultMale

Stichwörter der Autor:innen

CPRD AurumMother‐Baby Linkperinatal epidemiologyvalidation

Autor:innen und Institutionen

  • Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts, USA.
  • Amgen Ltd, Uxbridge, UK.
  • Boston University School of Public Health, Boston, Massachusetts, USA.

ORCID-Profile: Catherine Vasilakis-Scaramozza, Susan Jick

Förderung

  • Amgen Inc
  • Amgen

Zitieren

APA

Vasilakis-Scaramozza, C., Persson, R., Kafatos, G., Neasham, D., Hagberg, K. W., & Jick, S. (2025). Validation of Clinical Practice Research Datalink ( CPRD ) Aurum Mother‐Baby Link. Pharmacoepidemiology and Drug Safety, 34(2). https://doi.org/10.1002/pds.5860

Vancouver

Vasilakis-Scaramozza C, Persson R, Kafatos G, Neasham D, Hagberg KW, Jick S. Validation of Clinical Practice Research Datalink ( CPRD ) Aurum Mother‐Baby Link. Pharmacoepidemiology and Drug Safety. 2025;34(2). doi:10.1002/pds.5860

BibTeX
@article{VasilakisScaramozza2025,
  author = {Vasilakis-Scaramozza, Catherine and Persson, Rebecca and Kafatos, George and Neasham, David and Hagberg, Katrina Wilcox and Jick, Susan},
  title = {Validation of Clinical Practice Research Datalink ( CPRD ) Aurum Mother‐Baby Link},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  volume = {34},
  number = {2},
  doi = {10.1002/pds.5860}
}
Kostenlos starten →